BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15927668)

  • 1. GM-CSF does not increase CD20 antigen expression on chronic lymphocytic leukemia lymphocytes.
    Yağci M; Akar I; Sucak GT; Haznedar R
    Leuk Res; 2005 Jul; 29(7):735-8. PubMed ID: 15927668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
    Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
    Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1.
    Mankaï A; Buhé V; Hammadi M; Youinou P; Ghedira I; Berthou C; Bordron A
    Ann N Y Acad Sci; 2009 Sep; 1173():721-8. PubMed ID: 19758221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purine-rich box-1-mediated reduced expression of CD20 alters rituximab-induced lysis of chronic lymphocytic leukemia B cells.
    Mankaï A; Bordron A; Renaudineau Y; Martins-Carvalho C; Takahashi S; Ghedira I; Berthou C; Youinou P
    Cancer Res; 2008 Sep; 68(18):7512-9. PubMed ID: 18794139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia.
    Huh YO; Keating MJ; Saffer HL; Jilani I; Lerner S; Albitar M
    Am J Clin Pathol; 2001 Sep; 116(3):437-43. PubMed ID: 11554173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Density expression of the CD20 antigen on population of tumor cells in patients with chronic B-lymphocyte lymphoproliferative diseases].
    Suková V; Klabusay M; Coupek P; Brychtová Y; Doubek M; Mayer J
    Cas Lek Cesk; 2006; 145(9):712-6; discussion 716-7. PubMed ID: 17091727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients.
    Tam CS; Otero-Palacios J; Abruzzo LV; Jorgensen JL; Ferrajoli A; Wierda WG; Lerner S; O'Brien S; Keating MJ
    Br J Haematol; 2008 Apr; 141(1):36-40. PubMed ID: 18324964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor modulates CD 20 expression on cells from chronic lymphocytic leukemia: a new role for TNF alpha?
    Sivaraman S; Deshpande CG; Ranganathan R; Huang X; Jajeh A; O'Brien T; Huang RW; Gregory SA; Venugopal P; Preisler HD
    Microsc Res Tech; 2000 Aug; 50(3):251-7. PubMed ID: 10891891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of hematopoietic growth factors by human B lymphocytes: mechanisms and possible implications.
    Pistoia V; Corcione A; Baldi L; Zupo S; Dono M; Ferrarini M
    Stem Cells; 1993 Jul; 11 Suppl 2():150-5. PubMed ID: 7691321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass.
    Börgermann J; Friedrich I; Scheubel R; Kuss O; Lendemans S; Silber RE; Kreuzfelder E; Flohé S
    Thorac Cardiovasc Surg; 2007 Feb; 55(1):24-31. PubMed ID: 17285470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of interferon-alpha on CD20 antigen expression of B-cell chronic lymphocytic leukemia.
    Sivaraman S; Venugopal P; Ranganathan R; Deshpande CG; Huang X; Jajeh A; Gregory SA; O'Brien T; Preisler HD
    Cytokines Cell Mol Ther; 2000 Jun; 6(2):81-7. PubMed ID: 11108573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution and force spectroscopy of CD20 antigen-antibody binding on the B cell surface].
    Wang Q; Lu Y; Li S; Wang M; Cai J
    Sheng Wu Gong Cheng Xue Bao; 2011 Jan; 27(1):131-6. PubMed ID: 21553499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of fluorescein and phycoerythrin conjugates for quantifying CD20 expression on normal and leukemic B-cells.
    Wang L; Abbasi F; Gaigalas AK; Vogt RF; Marti GE
    Cytometry B Clin Cytom; 2006 Nov; 70(6):410-5. PubMed ID: 16967494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab reduces the number of peripheral blood B-cells in vitro mainly by effector cell-mediated mechanisms.
    Voso MT; Pantel G; Rutella S; Weis M; D'Alò F; Urbano R; Leone G; Haas R; Hohaus S
    Haematologica; 2002 Sep; 87(9):918-25. PubMed ID: 12217803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders.
    McCarron KF; Hammel JP; Hsi ED
    Am J Clin Pathol; 2000 Jun; 113(6):805-13. PubMed ID: 10874881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of calibration standards for antigen quantitation with flow cytometry in chronic lymphocytic leukemia.
    Rossmann ED; Lenkei R; Lundin J; Mellstedt H; Osterborg A
    Cytometry B Clin Cytom; 2007 Nov; 72(6):450-7. PubMed ID: 17565749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: roles of cyclooxygenase-2.
    Uemura Y; Kobayashi M; Nakata H; Kubota T; Saito T; Bandobashi K; Taguchi H
    Oncol Rep; 2007 Apr; 17(4):955-61. PubMed ID: 17342342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.